Longer term effects of the Angelina Jolie effect: Increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women

Breast Cancer Research

Volumn 17, Issue 1, 2015, Pages

  Evans, D Gareth ^a,b   Wisely, Julie ^a   Clancy, Tara ^b   Lalloo, Fiona ^b   Wilson, Mary ^a   Johnson, Richard ^a   Duncan, Jonathon ^a   Barr, Lester ^a   Gandhi, Ashu ^a   Howell, Anthony ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BILATERAL RISK REDUCING MASTECTOMY; BREAST CANCER; CANCER RISK; FAMILY HISTORY; GENE MUTATION; HUMAN; LETTER; MASS MEDIUM; MASTECTOMY; PATIENT REFERRAL; PUBLIC FIGURE; TUMOR SUPPRESSOR GENE; FEMALE; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; REFERRAL AND CONSULTATION;

EID: 84947918935     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0650-8     Document Type: Letter

References (5)

1. Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, et al. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014;16:442.
2. Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, et al. Uptake of risk reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age and time dependent. Cancer Epid Biomarkers Prev. 2009;18:2318-24.
3. Evans DG, Graham J, O'Connell S, Arnold S, Fitzsimmons D. Familial breast cancer: summary of updated NICE guidance. BMJ. 2013;346:f3829.
4. Evans DG, Howell A. Can the breast screening appointment be used to provide risk assessment and prevention advice? Breast Cancer Res. 2015;17:84.
5. Basu NN, Barr L, Ross GL, Evans DG. Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies. Int J Surg Oncol. 2015;2015:901046. doi: 10.1155/2015/901046.